Point72 Hong Kong’s CONMED CNMD Stock Holding History

Point72 Hong Kong’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,265	Closed	-$408K	–	1993
2022 Q2	$408K	Buy	+4,265	New	+$512K	0.02%	776
2020 Q1	–	Sell	-791	Closed	-$88K	–	1015
2019 Q4	$88K	Buy	+791	New	+$84.3K	0.02%	547
2019 Q3	–	Sell	-19	Closed	-$2K	–	1047
2019 Q2	$2K	Buy	+19	New	+$1.56K	﹤0.01%	987
2018 Q4	–	Sell	-4	Closed	–	–	935
2018 Q3	$0	Buy	+4	New	+$309	﹤0.01%	933

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 Hong Kong's CNMD Position: Q3 2022 in Review

Point72 Hong Kong sold out of CONMED (CNMD) in Q3 2022, closing a stake of 4,265 shares — an estimated $408K sold.

Point72 Hong Kong first reported a position in CNMD in Q3 2018 and held it in 4 quarters. The position peaked at $408K in Q2 2022. 250 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

Point72 Hong Kong reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 4,265 CONMED shares in Q3 2022, an estimated $408K.
Point72 Hong Kong first reported a position in CONMED in Q3 2018 and held it in 4 quarters.
Point72 Hong Kong's CONMED position peaked at $408K in Q2 2022.
250 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.